Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections present with
increased disease severity and poor clinical outcomes in diabetic patients compared with their …

… to symptomatic heart failure should be investigated. … biomarkers for predicting incident heart
failure in older people … people at increased risk of developing heart failure. The protocol and …

… a therapeutic gene expression cassette substitutes the viral E1 and/or E3 regions, have
advanced to clinical trials for applications in both therapeutic angiogenesis and heart failure. …

… , obesity, renal failure, and chronic heart failure (CHF). In most of these clinical conditions,
the presence of leg swelling is usually secondary to the primary disease [eg heart failure (HF)], …

… Resveratrol has been widely studied for its therapeutic potential due to its antioxidant, anti-inflammatory
and anti-microbial properties. In particular, resveratrol has shown promising …

… survival have led to the increasing prevalence of heart failure in the US population 3 and in
… in aspects of heart failure and their potential as novel clinical and therapeutic biomarkers. We …

… In this review, we discuss what is meant by “foundational” therapy for patients with heart failure
… offered by hospitalization for worsening heart failure to initiate and optimize foundational …

… of the energy metabolic changes that occur in heart failure. This includes distinguishing the
… , as well as heart failure associated with diabetes (ie, diabetic cardiomyopathy). Although we …

… with acute decompensated heart failure and is an important target for therapy. However, …
the outcomes of patients with acute decompensated heart failure. Although the majority of these …

… longa, is well known for its therapeutic potential in numerous disorders. However, there is
a lack of literature on the therapeutic potential of C. longa in contrast to curcumin. Hence, the …